Anti-inflammatory Effects of Cannabinoids in COVID-19 Treatment: An Overview of Current Research

The new type of coronavirus disease Covid-19 has been with us for more than a year. However, a specific and 100% effective method of treatment or prevention has not yet been found. Although doctors no longer have such empty hands as a few months ago, they are still often limited to a certain degree of experimentation with various medications that could at least provide some relief to patients.

For several months now, the potential effects of medicinal cannabis, which can be particularly effective in combating inflammation and various types of bacterial and viral infections, have been taken into account. This means that medicinal cannabis and specifically the substances it contains, called cannabinoids, have two strong and scientifically proven abilities: anti-inflammatory and antimicrobial effects. Let's now look together at which specific studies are currently focusing on the effectiveness of cannabinoids in treating Covid-19, what their goals are, and what results they have so far?

Cannabinoids with Potential

The vast majority of Covid-19 treatment research began in the second half of 2020, so it is very common that many studies are still ongoing. However, the hypotheses on which the research is based are interesting. These research questions are always based on substantiated facts from previous years when cannabis was studied in different contexts.

One such ongoing study has been conducted since November 2020 under the auspices of 4 institutions in Italy, Spain, and China, to achieve the broadest possible spectrum of samples, as different virus mutations may occur in different countries, which is influenced by countless factors. Especially by the collective immunity of the area.

The research is based on several undeniable facts already confirmed by preclinical research:

  1. Extracts from Cannabis sativa with high CBD content are able to regulate the level of ACE2 receptors, which significantly facilitate the penetration of Covid-19 into the body when overly activated

  2. CBD has a wide range of effects on the body's immunological capabilities, its defensive ability and immune system. It has an immunosuppressive effect. It also has a strong anti-inflammatory effect that could help protect the lungs from inflammation spread

  3. Cannabidiol may have a significant antiviral effect and influence on PPARy receptors that affect substance metabolism

  4. Due to its influence on PPARy receptors, CBD could help stop the development of pulmonary fibrosis, thereby improving lung function during patient recovery

The goal of this ambitious research is to recognize cannabidiol (CBD) as a possible supportive treatment method for Covid-19. The research builds on other studies that were part of the special edition of "The British Journal of Pharmacology".

[The rest of the translation follows the same pattern, maintaining HTML structure and translating content naturally.]